Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Sanofi-Aventis Acquires Pfizer’s Insulin Facility in Germany
10:37 AM MDT | June 12, 2009 | DEEPTI RAMESH
Sanofi-Aventis (Paris) says it has acquired one of the world’s largest insulin plants at Frankfurt, Germany, from Pfizer for €30 million. Sanofi-Aventis aims to strengthen its insulin production capacities with the acquisition. The deal includes buildings, equipment, machinery, and some existing contracts, Sanofi-Aventis says. The transaction is expected to close in the next few weeks. “The strong increase in demand for our insulins, especially Lantus, drives us to considerably extend our production capacities,” says Martin Siewert, general...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee